Skip to Content
Merck
  • Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.

Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.

Transplantation (2005-10-08)
Laura Pierdomenico, Laura Bonsi, Mario Calvitti, Damiano Rondelli, Mario Arpinati, Gabriella Chirumbolo, Ennio Becchetti, Cosetta Marchionni, Francesco Alviano, Valentina Fossati, Nicola Staffolani, Michele Franchina, Alberto Grossi, Gian Paolo Bagnara
ABSTRACT

Bone marrow mesenchymal stem cells (MSCs) are currently being investigated in preclinical and clinical settings because of their multipotent differentiative capacity or, alternatively, their immunosuppressive function. The aim of this study was to evaluate dental pulp (DP) as a potential source of MSCs instead of bone marrow (BM). Flow cytometric analysis showed that DP-MSCs and BM-MSCs were equally SH2, SH3, SH4, CD29 and CD 166 positive. The in vitro proliferative kinetics of MSCs were measured by 3H-thymidine incorporation uptake. The immunosuppressive function of MSCs was then tested by coculturing PHA-stimulated allogeneic T cells with or without MSCs for 3 days. BM-MSCs could be differentiated in vitro into osteogenic, chondrogenic and adipogenic lineages. DP-MSCs showed osteogenic and adipocytic differentiation, but did not differentiate into chondrocytes. Although DP-MSCs grow rapidly in vitro between day 3 and day 8 of culture and then decrease their proliferation by day 15, BM-MSCs have a stable and continuous proliferation over the same period of time. The addition of DP-MSCs or BM-MSCs resulted in 91 +/- 4% and 75 +/- 3% inhibition of T cell response, respectively, assessed by a 3H-thymidine assay. Dental pulp is an easily accessible and efficient source of MSCs, with different kinetics and differentiation potentialities from MSCs as isolated from the bone marrow. The rapid proliferative capacity together with the immunoregulatory characteristics of DP-MSCs may prompt future studies aimed at using these cells in the treatment or prevention of T-cell alloreactivity in hematopoietic or solid organ allogeneic transplantation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dexamethasone, meets USP testing specifications